Skip to main content
Top
Published in: Pharmaceutical Medicine 2/2000

01-04-2000 | Original Article

Assessment methods for quality of life in cancer patients: the FACIT measurement system

Author: David Cella

Published in: Pharmaceutical Medicine | Issue 2/2000

Login to get access

Summary

The Functional Assessment of Chronic Illness Therapy (FACIT) measurement system is a collection of 27 quality of life (QOL) scales, with several more in development, targeted at the management of chronic illnesses including cancer (FACT), human immunodeficiency virus (HIV) infection (FAHI), and multiple sclerosis (FAMS). The core FACIT scale (FACT-G) consists of a general questionnaire with 27 items related to four dimensions of health: physical, functional, social, and emotional well-being. There are also symptom- and treatment-specific scales as well as assessments for other areas of concern (e.g. spirituality and palliative care). Many of the questionnaires are available in over 30 languages. The validity, reliability, and the sensitivity to change in health status over time of the FACIT questionnaires have been well documented. Currently, the FACIT scales have been implemented in Phase II and III clinical trials and other cancer-related treatment evaluations. Future efforts in improving the FACIT measurement system include identification of items that are sensitive to specific patient populations, collection of data to establish national normative and bench mark scores, construction of a QOL item bank, and development of computerized adaptive testing programmes (CAT) to measure precisely a given concept based on ongoing responses.
Literature
1.
go back to reference Moore MJ, Osoba D, Murphy K, Tannock IF, Armitage A, Findlay B, Coppin C, Neville A, Venner P, Wilson J. Use of palliative end points to evaluate the effects ofmitoxantrone andlow-dose prednisonein patients with hormonally resistant prostate cancer. J Clin Oncol 1994; 12:689–94.PubMed Moore MJ, Osoba D, Murphy K, Tannock IF, Armitage A, Findlay B, Coppin C, Neville A, Venner P, Wilson J. Use of palliative end points to evaluate the effects ofmitoxantrone andlow-dose prednisonein patients with hormonally resistant prostate cancer. J Clin Oncol 1994; 12:689–94.PubMed
2.
go back to reference Cella DF. Measuring quality of life in palliative care. Semin Oncol 1995; 22(2 Suppl 3):73–81.PubMed Cella DF. Measuring quality of life in palliative care. Semin Oncol 1995; 22(2 Suppl 3):73–81.PubMed
3.
go back to reference Chang C, Bresnahan B, Gagnon D, Lent L, Zagari M, McNulty P, Vercammen E, Cella D. Cross-language validation of the Functional Assessment of Cancer Therapy — Anemia (FACT-An) questionnaire. Eur J Cancer 1999; 35 (Suppl 4):S359.CrossRef Chang C, Bresnahan B, Gagnon D, Lent L, Zagari M, McNulty P, Vercammen E, Cella D. Cross-language validation of the Functional Assessment of Cancer Therapy — Anemia (FACT-An) questionnaire. Eur J Cancer 1999; 35 (Suppl 4):S359.CrossRef
4.
go back to reference Chang C-H, Cella D. Equating health-related quality of life instruments in applied oncology settings. Physical Medicine and Rehabilitation: State of the Art Reviews 1997; 11:397–406. Chang C-H, Cella D. Equating health-related quality of life instruments in applied oncology settings. Physical Medicine and Rehabilitation: State of the Art Reviews 1997; 11:397–406.
Metadata
Title
Assessment methods for quality of life in cancer patients: the FACIT measurement system
Author
David Cella
Publication date
01-04-2000
Publisher
Springer International Publishing
Published in
Pharmaceutical Medicine / Issue 2/2000
Print ISSN: 1178-2595
Electronic ISSN: 1179-1993
DOI
https://doi.org/10.2165/00124363-200004000-00007

Other articles of this Issue 2/2000

Pharmaceutical Medicine 2/2000 Go to the issue